Latest: Take your FFPE DNA and RNA extraction to the next level
Latest: First step to In Vitro Diagnostic Regulation (IVDR) certification for ZeptoMetrix
Latest: Cell therapy: A GMP-compatible solution for ensuring clonality during iPSC manufacturing
Latest: Optimized microplate for cannabis sample processing
Latest: New line of electrochemistry bench meters simplifies pH, conductivity, and dissolved...
Latest: Food Analysis Summit 2022: AI and nanotechnology in food analysis, food safety and...
Latest: 7 upcoming webinars to empower your research
Take your FFPE DNA and RNA extraction to the next level
The value of assay-ready cells in providing biologically relevant data for robust therapeutic...
Tosoh Bioscience launches its holistic multi-column chromatography solution for downstream process...
Fluxion launches a fully packaged ion channel screening solution
Trending in Analytical Chemistry: 6 HPLC systems rated by you
Explore the latest webinars to expand your research knowledge
Managing the risk of nitrosamines in medicinal drugs
Your essential guide to preparative LC
Automated solid phase extraction of PAH compounds utilizing the SPE-DEX 5000
Maestro TrayZ: The scalable live-cell assay system
Keep your experiments fresh with general purpose laboratory refrigerators and freezers
Top FlowCam studies for biopharmaceuticals
Cell Imaging Technology
Clinical Laboratory Automation
Flow Cytometers for Screening
Virtual Cancer and Immunology Summit
22 Nov 22 - 22 Nov 22
NEW: Environmental Analysis:...
06 Dec 22 - 12 Dec 22
In this guest editorial, Joe Fredette, senior business development manager with the Biopharmaceuticals team at Waters, reflects on the recent TIDES meeting - the industry’s largest event for oligonucleotide and peptide therapeutics.